JAKOB GRAFF: Open Payments
NPI 1154773133 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 18 payments from 12 companies in 2025. Trend: 2023 $98 · 2024 $463 · 2025 $650
Food & beverage: $550Education: $100
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 2 | $192 |
| Sumitomo Pharma America, Inc. | 5 | $115 |
| Janssen Biotech, Inc. | 1 | $100 |
| 180 Medical, Inc. | 2 | $58 |
| UROGEN PHARMA, INC. | 1 | $35 |
| Astellas Pharma US Inc | 1 | $29 |
| Medtronic, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: PROVENGE, ERLEADA, GEMTESA, ORGOVYX, Xtandi, JELMYTO, CURE CATHETER, ALTAVIVA.
Industry payments across CO — which companies pay providers there.
